Results 1 to 10 of about 123,700 (116)
Circulating Biomarkers in Coronary Microvascular Dysfunction
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Coronary microvascular dysfunction is an underdiagnosed pathologic process that is associated with adverse clinical outcomes. Biomarkers, molecules measurable in the blood, could inform the clinician by aiding in the diagnosis and management of coronary ...
Teja Chakrala +4 more
doaj +3 more sources
Single Nucleotide Polymorphisms in Coronary Microvascular Dysfunction
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseCoronary microvascular dysfunction is an underdiagnosed pathologic process that is associated with adverse clinical outcomes. There are data to suggest that coronary microvascular dysfunction, in some cases, may be genetically determined.
Andrew P. Stein +5 more
doaj +3 more sources
Coronary Microvascular Dysfunction in Cardiomyopathies: Insights on Clinical and Prognostic Roles [PDF]
Reviews in Cardiovascular MedicineCoronary microvascular dysfunction (CMD) is a key driver of ischemia and prognosis across several non-ischemic cardiomyopathies. This review summarizes the main tools for diagnosing microvascular dysfunction and available evidence on CMD incidence and ...
Federico Giacobbe +20 more
doaj +2 more sources
Microvascular Dysfunction in Patients with Prediabetes: Novel Methods Identify Impaired Microcirculation [PDF]
LifeBackground: Skin and myocardial microvascular dysfunction in prediabetes remains underexplored, and limited studies have investigated the microcirculation in prediabetes in multiple vascular beds.
Stamatina Lamprou +10 more
doaj +2 more sources
A review of cardio-pulmonary microvascular dysfunction in pulmonary hypertension
American Heart Journal Plus, 2023 Microvascular dysfunction progressing to pulmonary hypertension can be a primary cause of right ventricular failure or a secondary cause because of an underlying systemic illness.
Cyrus Vahdatpour +6 more
doaj +1 more source
INOCA/ANOCA: Mechanisms and novel treatments
American Heart Journal Plus, 2023 Angina or ischemia with no obstructive coronary disease (ANOCA/INOCA) is a common but under-treated condition due to poorly understood pathophysiologic mechanisms, limited diagnostic tools, and lack of proven targeted therapy.
Namrita D. Ashokprabhu +3 more
doaj +1 more source
Coronary Microvascular Dysfunction: Epidemiology, Clinical Presentation, Diagnosis and Treatment
Рациональная фармакотерапия в кардиологии, 2023 In a significant number of patients with symptoms of angina pectoris or myocardial infarction with ischemic changes in the myocardium, according to the results of instrumental research methods, there is no hemodynamically significant stenosis of the ...
E. L. Trisvetova
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2022 BackgroundUp to 50% of acute myocardial infarction (MI) patients present with microvascular dysfunction, after a successful percutaneous coronary intervention (PCI), which leads to worse clinical outcomes.
Marta Silva +12 more
doaj +1 more source
Impaired Coronary and Renal Vascular Function in Spontaneously Type 2 Diabetic Leptin-Deficient Mice. [PDF]
PLoS ONE, 2015 Type 2 diabetes is associated with macro- and microvascular complications in man. Microvascular dysfunction affects both cardiac and renal function and is now recognized as a main driver of cardiovascular mortality and morbidity.
Helena U Westergren +9 more
doaj +1 more source
Small vessel disease: Connections between the kidney and the heart
American Heart Journal Plus, 2023 Small vessel disease is characterized by global dysfunction of the microvascular system leading to reduced perfusion of various organ systems. The kidney is significantly vulnerable for microvascular dysfunction given its intricate capillary network and ...
Jacob K. Meariman +4 more
doaj +1 more source